key: cord-0875887-dcy6tcmp
authors: Rani, Isha; Goyal, Anmol; Bhatnagar, Mini; Manhas, Sunita; Goel, Parul; Pal, Amit; Prasad, Rajendra
title: Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19
date: 2021-06-13
journal: Nutr Res
DOI: 10.1016/j.nutres.2021.05.008
sha: c999ddccd78a3b7d6a5f3297735e6148a75e3b93
doc_id: 875887
cord_uid: dcy6tcmp

Novel coronavirus disease 2019 (COVID-19) has spread across the globe; and surprisingly, no potentially protective or therapeutic antiviral molecules are available to treat severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, zinc (Zn) and copper (Cu) have been shown to exert protective effects due to their antioxidant, anti-inflammatory and antiviral properties. Therefore, it is hypothesized that supplementation with Zn and Cu alone or as an adjuvant may be beneficial with promising efficacy and a favorable safety profile to mitigate symptoms, as well as halt progression of the severe form of SARS-CoV-2 infection. The objective of this review is to discuss the proposed underlying molecular mechanisms and their implications for combating SARS-CoV-2 infection in response to Zn and Cu administration. Several clinical trials have also included the use of Zn as an adjuvant therapy with dietary regimens/antiviral drugs against COVID-19 infection. Overall, this review summarizes that nutritional intervention with Zn and Cu may offer an alternative treatment strategy by eliciting their virucidal effects through several fundamental molecular cascades, such as, modulation of immune responses, redox signaling, autophagy, and obstruction of viral entry and genome replication during SARS-CoV-2 infection.

for massive systemic production of proinflammatory cytokines, also known as a cytokine storm [1] [2] [3] . This cytokine storm is clinically evident by acute respiratory distress syndrome (ARDS) and other systemic effects [4, 5] .

Indeed, therapeutic strategies against SARS-CoV-2 are mostly focused on its immunopathology and/or tailored to directly control viral replication by using off-label or conventional pharmacological therapies. Generally, people with an enfeebled immune system are at higher risk of infectious disease, and COVID-19 is no exception. Therefore, it is critical to strengthen the body's immune response to combat COVID-19 disease. On the basis of the available literature, it is clear that maintaining optimum levels of Zn and Cu may stimulate both innate and adaptive immune systems in the course of a viral infection (readers are referred to seminal review articles for details) [6, 7] . Furthermore, both Zn and Cu may be promising pharmaceutical prophylactic modalities against COVID-19 infection due to their potent antiviral and antioxidant properties. It has been suggested that these essential metal ions might target numerous mechanistic pathways to battle against SARS-CoV-2 infection. Therefore, this review is mainly focused on the potential underlying molecular mechanisms used by Zn and Cu to counteract the COVID-19 pandemic. We have also highlighted the globally ongoing clinical trials of Zn interventions as an adjunct therapy in the treatment of COVID-19 disease.

SARS-CoV-2 infection not only clinically manifests with respiratory symptoms but also exhibits gastrointestinal (GI) complications [8] . The cellular entry of SARS-CoV-2 is mediated by membrane bound angiotensin-converting enzyme 2 (ACE) receptors and host transmembrane serine protease 2 (TMPRSS2), which are highly expressed on GI epithelial cells compared to lung alveolar cells [9, 10] . The molecular pathogenesis of the vulnerability of the digestive system to SARS-CoV-2 is driven by direct cytotoxic consequences, which includes an increase in the permeability of the virus at the lumen apical membrane, resulting in enteric symptoms such as diarrhea, followed by invaded enterocyte damage, malabsorptions, or distressed intestinal secretion ( Figure 1 ) [11] . A pooled analysis showed that the overall diarrhea rate was 10.4% in patients with SARS-CoV-2 infection [12] . Diarrhea is characterized by direct loss of the villus as well as inflammation at the intestinal mucosa. The nutritional consequences of diarrhea cause malabsorptions of nutrients, which are further worsened by viral infection (Figure 1 ). For instance, Zn and Cu are known to be depleted due to malabsorptions, diarrheal episodes, pathogen translocations, and celiac disease caused by atrophic changes in intestinal epithelial cells due to compromised GI epithelial barrier function [13] [14] [15] [16] . Remarkably, Zn and Cu supplementation is known to improve the duration and frequency of diarrhea as well as celiac disease. It therefore leads to the recovery of the absorption of water, nutrients and electrolytes from the mucosa to the intestinal epithelium, which eventually causes quicker regeneration of the intestinal epithelium [14] [15] [16] . Furthermore, marginal or severe Zn and Cu deficiency may be attributable to several acquired factors, such as geographical, socioeconomic, nutritional, or certain pathological conditions, such as chronic viral infections, and may be inherited [17] . Thus, it is critical to maintain the balance between the absorption and excretion of these metals, which is regulated by transporter proteins in intestinal epithelial cells, such as Zrt-/Irt-like protein (ZIP4), zinc transporters (ZnT1), copper transporter protein (CTR1) and copper-ATPase (Cu-ATP7A). ZIP4 causes the import of Zn ions from the lumen of the intestine into enterocytes, whereas ZnT-1 exports them through the basolateral side of enterocytes into portal blood [18] . After transport, some Zn may bind to metallothionein (MT) and be transported to peripheral tissues. On the other hand, copper is absorbed through CTR1 in enterocytes and further transferred to human antioxidant protein 1 (ATOX1), a copper metallo chaperone protein that delivers Cu ions from the cytosol to ATP7A and ATP7B. Similarly, cytochrome c oxidase (COX) and copper chaperone for superoxide dismutase (CCS) distribute Cu ions to cytochrome C oxidase and superoxide dismutase (SOD), respectively [19] . MT binds excess cytosolic copper, thereby conferring protection against Cu toxicity [20] .

Any disruption in cellular homeostasis of Zn and Cu is associated with pathological disorders, including susceptibility to infections. Therefore, we speculate that any dietary or therapeutic modulation of Zn and Cu at their optimal concentrations will not only replenish the stores of enterocytes to mitigate gastrointestinal symptoms exacerbated by COVID-19 infection but will also make the immune system competent enough to curtail viral replication.

Data gleaned from animal and clinical studies have highlighted the prominent roles of Zn in various biological processes as a cofactor, signaling molecule and structural element. Zn, an essential trace element, is a constituent of more than 300 metalloenzymes that participate in several cellular and metabolic processes, such as cell proliferation, differentiation, stabilization of cell membranes, redox signaling, apoptosis, RNA/DNA synthesis, and metabolism of microand macronutrients [21] . It acts as a cofactor for an antioxidant enzyme (Zn/Cu SOD) that is responsible for the removal of reactive oxygen species (ROS), a byproduct of inflammation. Zn also inhibits the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which actively communicates during host defense responses to viral infections. Likewise, Zn induces the production of cysteine-rich MTs, which are excellent scavengers of hydroxyl ( . OH) radicals [22] . The essential role of Zn has also been reported for the development and integrity of both innate and adaptive immune systems at multiple molecular, cellular and systemic levels [23] ( Figure 2 ). Zn acts as a central regulator of all immunological mediators by controlling their basic cellular functions, including DNA replication, RNA transcription, cell division and cell activation. In short, Zn is involved in the development and function of cells regulating innate immunity, such as neutrophils, NK cells and macrophages, which are important as the first line of defense against infections. Zn stimulates macrophages to produce interleukin (IL)-12, which further sensitizes NK cells and T cytotoxic cells. It also fosters the viral killing activity of NK cells by upregulating perforin expression and IL-2 levels. An in vivo study observed that Zn deficiency impairs NK cell activity, cytokine production, generation of oxidative bursts, and phagocytosis of macrophages and neutrophils. In addition, insufficient levels of Zn can accelerate the production of proinflammatory cytokines, including IL-1β, IL-6 and tumor necrosis factor (TNF)-α, by subsequently activating canonical NF-κB signaling, a precursor for the pathogenesis of inflammatory diseases, such as ARDS and sepsis syndrome. Zn has been demonstrated to affect the activity of thymulin, a thymic hormone required for the differentiation of immature T cells in the thymus, as well as the functions of mature peripheral T cells, including cytotoxicity and IL-2 production. The association of immune integrity with Zn status is clearly evident from observing the effects mediated by Zn deficiency, including lymphopenia, thymic atrophy, and impaired cell-and antibody-mediated immune responses, which occur due to high losses of precursor T and B cells in the bone marrow by activation of the apoptotic cascade. Thus, low levels of Zn affect adaptive immunity by inhibiting the effects of B lymphocytes and immature and mature T cells (CD4-expressing Th cells and CD8-expressing cytotoxic T lymphocytes). Zn deficiency causes a reduction in the number of CD8/CD73 coexpressing T cells required for antigen recognition, proliferation and cytolytic processes [23] .

Alternatively, impairment in the polarization of mature Th cells can cause an imbalance between Th1 and Th2 cells and thereby lead to unbalanced cell-mediated immune responses. Zn deficiency also indicates decreased interferon (IFN)-γ production, a major component of the Th1 cytokine panel that exacerbates the incidence of infections [24, 25] . Moreover, Zn exhibits antioxidant properties and maintains membrane architecture at the cytoskeletal level. Znmediated membrane stabilization may be related to phagocytic depression, consumption of oxygen and bactericidal activity in phagocytic cells [26] . Remarkably, it is also an important constituent of nutritional immunity [25] . Importantly, older people, infants and chronic alcoholics are particularly susceptible to Zn deficiency, thereby increasing their chances of acquiring life-complicating viral infections [27]. [35] and hepatitis C virus (HCV) [36] . Interestingly, Zn displays antiviral properties by a number of physical processes, including virus attachment, penetration, infection, uncoating and replication [37] .

Zn regulates numerous biological processes, such as the activity and expression of various cellular enzymes and transcription factors. In addition, Zn is probably an important cofactor for numerous viral proteins as well. Zn facilitates proteolytic processing of viral polyproteins by misfolding, which alters the architecture of the virus and its protease activity, as observed in the picorna and polioviruses [29, 38, 39] . Moreover, Zn may potentially inhibit direct membrane fusion of the semliki forest virus by binding to a particular histidine residue present on the viral protein E1 at low endosomal pH [40] . [42] . Zn acts as a membrane stabilizer that may directly prevent the entry of the virus into the cell [43] . Overexpression of MTs and Zn-binding proteins, involved in the storage and transfer of Zn inhibited the replication of flaviviruses and alphaviruses. These effects of MTs can be explained by the fact that they may sequester Zn from viral MTs directly or indirectly, promoting antiviral signaling by acting as Zn chaperones [37] . The administration of Zn also ameliorates oxidative stress induced by the RSV and influenza virus by triggering MTs to release Zn into the cytoplasm, which maintains the cellular redox state [44] . Boudreault et al. demonstrated that dietary Zn deficiency can also aggravate ventilator-induced lung injury in a murine model. A significant reduction in the levels of plasma Zn levels in patients with ARDS is suggestive of the remedial role of Zn for lung-protective interventions in patients requiring mechanical ventilation [45] .

There is scant information available on the role and effect of Zn in COVID-19 disease. Much of the current knowledge about the use of Zn as an immunomodulatory agent and antiviral therapy has originated from studies performed with other viral diseases [37] . Based on these studies, the An imbalance in the immune response is one of the important hallmarks of COVID-19 infection.

The cellular entry of SARS-CoV-2 activates NF-κB, a main stimulator of proinflammatory cytokines also known as a cytokine storm, that is responsible for the progression of ARDS [2, 3] .

Zn exerts anti-inflammatory activity by subsequently suppressing inhibitory kappa kinase (Iκκ) activity and NF-κB signaling, which may ultimately downregulate the production of proinflammatory cytokines [46, 47] . Moreover, inhibition of NF-κB may enhance IFNmediated antiviral effects. Thus, therapeutic administration of Zn could be highly beneficial for attenuating a cytokine storm mediated by COVID-19 infection.

Insufficient levels of both type I and type II IFNs were reported in COVID-19 patients.

However, Zn may activate the synthesis of IFN-α and IFN-γ by modulating the expression of MTs and eventually potentiating their antiviral potential. Mechanistically, augmented intracellular Zn levels activate metal-responsive transcription factor (MTF1), which binds to the metal responsive element (MRE) in MT gene promoters to stimulate their transcription [45, 48] .

MTs are also described as interferon stimulated genes (ISGs) that increase the levels of Thus, RdRPs are key targets for antiviral research due to their crucial function in the viral replication cycle; hence, targeting RdRP of SARS-CoV-2 may offer an appropriate therapeutic tool for antiviral drug development.

Another potential Zn related therapeutic strategy affects the expression of ACE2 receptors, which are required by SARS-CoV-2 for entry into target cells [9] . ACE2 is a zinc metalloenzyme expressed on type 2 pneumocytes and requires Zn for its activity. Zn is crucial for stabilizing protein architectures and affecting the affinity between substrate and metalloenzymes. Thus, Zn homeostasis may influence ACE2 expression, as Zn dependent activity has been reported for other zinc-metalloenzymes and recombinant human ACE2 activity [67, 68] . In fact, Zn decreases the activity of NAD-dependent deacetylase sirtuin-1 (SIRT-1), which is essential for controlling ACE2 expression and thereby possibly blocks virus entry [69] .

Coronavirus infection leads to an impairment in mucociliary clearance with destruction of the ciliated epithelium [70] . In vitro studies have reported that Zn treatment improves ciliary length and beat frequency in the bronchial epithelium [71, 72] . Improvement in ciliary clearance will not only alter the removal of virus particles but also ameliorate the risk of bacterial coinfections.

This approach may be beneficial to alleviate abnormal mucociliary clearance mediated by 

The database of clinical trials on Zn interventions in COVID-19 infection is given in Table 1 and has been studied to understand the benefits and problems of distinct therapeutic regimens. As of Table 1 ). The outcomes of these randomized controlled trials are highly anticipated due to the high rate of mortality and morbidity caused by COVID-19 worldwide. During viral infection, Cu acts as an essential micronutrient for both pathogens and animal hosts;

however, high levels of Cu can also be toxic due to its redox reactions. This phenomenon can be explained by the fact that macrophages are able to attack pathogens at high Cu load during an infection, but at the same time, higher levels of Cu have been reported at the sites of lung infection [82] . Thus, excess levels of Cu and its deficiency may both lead to abnormal biological functions or damage, which highlights its dominant role in host-pathogen interactions [83] . ultimately destroy viral genomes as well as their morphology, such as by disintegration of envelopes and dispersal of surface spikes [94, 95] . Copper iodide induces the production of free radicals, including ·OH and O 2 · -, which exhibit virucidal effects by the subsequent degradation of viral proteins such as hemagglutinin and neuraminidase [96] . The antiviral effect of Cu is also boosted by the addition of peroxides in mixtures of Cu-(II) ions [87] . Moreover, a range of Cu alloys have also been observed to rapidly inactivate the human coronavirus by enhancing ROS generation [97] . Cu also interferes with important proteins of the virus and therefore is known to cause virus inactivation. In vitro studies have reported that Cu intervention caused 99%

inactivation of viruses after 30 minutes, and the effect was observed to be more pronounced in enveloped viruses [98, 99] . Oxidized Cu oxide (CuO) nanoparticles are widely used as catalysts that cause inactivation of viruses [100] . The killing of viruses on contact with metallic Cu surfaces is well studied, and this antivirulence effect is mediated by damaging the viral genome.

For instance, Cu surfaces pulverize genomic material of infectious influenza A virus particles by binding to and cross-linking between and within the strands [84] . Likewise, nanosized Cu iodide particles have also been reported to display the inactivation of the H1N1 influenza virus.

Therefore, Cu and its alloys may be considered useful materials for protection against viral attack, such as using Cu-coated filters, face masks and protective clothing. Additionally, the antipathogenic effect of Cu has also been clearly explained by a recent study describing that activated macrophages accumulate Cu in the phagosome by increasing the expression of the Cu ATP-7A protein [110] . Thus, increased Cu content in the phagosome exerts harmful and toxic effects on the pathogens, probably by lowering pH, generating ROS and reactive nitrogen species (RNS), amplifying proteases and iron starvation in order to cope with invading pathogens.

Strikingly, Cu may activate autophagy to maintain the cell's antiviral effect [111] . Autophagy is often initiated to eliminate infection by delivering viral particles for lysosomal degradation and further integrates with Toll-like receptor (TLR)-7, an innate pattern recognition receptor, to mount typical type I IFN-mediated viral clearance by activating JAK/STAT signaling [112] .

Taken together, these findings may support future studies for using Cu as a potential antiviral regimen to combat the COVID-19 pandemic.

The killing power of Cu against coronavirus infection is detailed in Table 2 . It has been speculated that any of the aforementioned mechanistic approaches might be followed by Cu to prevent COVID-19 infection (Figure 4 ). According to a scientific report, lower serum cholesterol levels have been reported in 71 patients infected with COVID-19 with respect to healthy subjects particles [115] . Therefore, it has been inferred that plasma Cu may have a role in regulating the above phenomena by affecting cholesterol levels. An in vivo study showed that Cu ions block the activity of papain-like protease-2, which is essential for the process of SARS-CoV-1 replication [116, 117] . Treatment with copper gluconate mitigates SARS-CoV-2 infection by more than 70%

in Vero E6 cells [118] . The phenomenon of 'contact killing' by Cu has been known since ancient times. A recent study conducted by the National Institute of Health (NIH) reported that SARS-CoV-2 and SARS-CoV-1 could not survive on Cu surfaces after more than 4 and 8 hours,

respectively [119] . Similarly, SARS-CoV-1 is exceptionally sensitive to Cu/Al 2 O 3 surfaces for 5-20 minutes [120] . Recently, the inactivation efficiency of SARS-CoV-2 was observed to be 96% and 99.2% after 2 and 5 hours, respectively, when fabricating copper coatings using cold-spray technology [121] . Cu produced by Luminore CopperTouch™ technology also inactivates more than 99% of SARS-CoV-2 titers in 2 hours [122] . The coating of cuprous oxide (Cu 2 O) particles bound with polyurethane significantly reduces the SARS-CoV-2 titer by approximately 99.9% in 1 hour compared to the uncoated sample [123] . In addition, masks impregnated with copper oxide microparticles also reduce infectious titers of SARS-CoV-2 by more than 99.9% within 1 minute of contact [124] . Pezzotti et al. also reported that Cu exhibits more than 99% SARS-CoV-2 inactivation after 1 and 10 minutes of exposure [125] . Furthermore, the evaluation of the antiviral potential of copper alloy surfaces may serve as a first-line defense measure to control COVID-19 infection. Currently, there is no evidence or knowledge available regarding the therapeutic effect of Cu supplementation against COVID-19 infection. Therefore, more preclinical studies and multicenter prospective clinical trials on this subject are urgently required.

According to the NIH (available at https://ods.od.nih.gov/), the current recommended dietary allowance (RDA) for Zn is 8 to 11 mg/day and Cu is 900 μg/day for adult females and males.

Remarkably, Zn and Cu act antagonistically due to competitive absorption relationships. In fact, excessive supplemental or medicinal Zn intake over long periods of time can lead to Cu deficiency and vice versa. Accordingly, this imbalance acts as a contributing factor for disease pathogenesis; therefore, supplementation should be at concentrations sufficient for an optimum response [126, 127] [124, 125] . However, a detailed understanding of the mechanistic impact of Zn and Cu interactions in regulating virus core assembly and the susceptibility of cellfree viruses to environmental metal ions or their chelation needs to be elucidated, as it may be beneficial to impede a wide range of infections.

We speculate that supplementing Zn and Cu could be an important protective or therapeutic surfaces

The inactivation efficiency was Hutasoit et al. 2020 [115] 96% and 99.2% for the as-deposited copper coating after a 2-hr and 5-hr incubation time

Infection was reduced by 71%, 77%, Rodriguez et al. 2020 [116] and 78% with 25, 50, and 100 μM of copper gluconate in Vero-E6 cells

Inactivation was more than 99% in 2 hrs Mantlo et al. 2020 [117] after exposure to copper produced by Luminore CopperTouch™ technology

The masks impregnated with copper-Borkow et al. 2020 [118] oxide microparticles decreased SARS-CoV-2 infection by more than 99.9% within 1 minute

Coating of cuprous oxide (Cu 2 O) particles Behzadinasab et al. 2020 [119] bound with polyurethane significantly reduced infectious titer by about 99.9% in 1 hr

Cu showed >99% viral inactivation Pezzotti et al. 2020 [120] at 1 and 10 minutes of exposure

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

Cytokine storm induced by SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19: immunopathology and its implications for therapy

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Nutrition, immunity and COVID-19

Zinc and COVID-19: Basis of Current Clinical Trials

Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv

Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts

COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

Diarrhea during COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management

Malabsorption syndrome, Encyclopedia of Food Sciences and Nutrition

Zinc and gastrointestinal disease

Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial

Copper deficiency in celiac disease

Assessment of trace element status

Zn and Cu Transport Proteins: A Brief Overview from Physiological and Molecular Perspectives

Copper transporters and copper chaperones: roles in cardiovascular physiology and disease

Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels

Discovery of Zinc for Human Health and Biomarkers of Zinc Deficiency, Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals

Regulation of metallothionein gene expression by oxidative stress and metal ions

Zinc in human health: effect of zinc on immune cells

Multiple impacts of zinc on immune function

Zinc in infection and inflammation

Effect of zinc salts on respiratory syncytial virus replication

Inhibition of HIV-1 infection by zinc group metal compounds

Zinc: A complementary factor in the treatment of chronic hepatitis C?

The Role of Zinc in Antiviral Immunity

The mechanism of the antiherpetic activity of zinc sulphate

Review on the role of Zn 2+ ions in viral pathogenesis and the effect of Zn 2+ Ions for host cell-virus growth inhibition

Identification of a specific region in the e1 fusion protein involved in zinc inhibition of semliki forest virus fusion

Inhibition of vaccinia virus maturation by zinc chloride

Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase

A novel form of host defence: membrane protection by Ca 2+ and Zn 2+

Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in

Zinc deficiency primes the lung for ventilator-induced injury

ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB

Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB

Metal responsive transcription factor 1 (MTF-1) regulates zinc dependent cellular processes at the molecular level

Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells

SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) -A drug repurposing study

Concentration-dependent effects of zinc on angiotensin-converting enzyme-2 activity

Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures

The effects of coronavirus on human nasal ciliated respiratory epithelium

Zinc supplementation effect on the bronchial cilia length, the number of cilia, and the number of intact bronchial cell in zinc deficiency rats

Zinc increases ciliary beat frequency in a calcium-dependent manner

Copper is a potent inhibitor of both the canonical and non-canonical NF-κB pathways

Copper decreases gene expression of TNF-α, IL-10, and of matrix metalloproteinases MMP-2 and MMP-9 in isolated perfused rat livers

Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells

The Yin and Yang of copper during infection

Candida albicans adapts to host copper during infection by swapping metal cofactors for superoxide dismutase

Inactivation of influenza A virus on copper versus stainless steel surfaces

Copper as a biocidal tool

Mechanism of copper-mediated inactivation of herpes simplex virus

Virus inactivation by copper or iron ions alone and in the presence of peroxide

Interactions of copper complexes with nucleic acids

Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles

Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms

The effects of copper and other ions on the ribonucleic acid polymerase activity of isolated rat liver nuclei

Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents

Norovirus RNA-dependent RNA polymerase: A computational study of metal-binding preferences

Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied by loss of capsid integrity

Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials

Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Inactivation and morphological changes of avian influenza virus by copper ions

Cupric and ferric ions inactivate HIV

Antiviral activities of Cu 2+ ions in viral prevention replication, RNA degradation, and for antiviral efficacies of lytic virus, ROS-mediated virus, copper chelation

A novel anti-influenza copper oxide containing respiratory face mask

Protective role of macrophagederived ceruloplasmin in inflammatory bowel disease

Hematological findings and complications of COVID-19

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions

Unexpected role of ceruloplasmin in intestinal iron absorption

Bactericidal effect of Fe 2+ , ceruloplasmin, and phosphate

Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway

The Influenza Virus H5N1 Infection Can Induce ROS Production for Viral Replication and Host Cell Death in A549 Cells Modulated by Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression

A role for the ATP7A coppertransporting ATPase in macrophage bactericidal activity

Copper -a novel stimulator of autophagy

The Cross-Regulation Between Autophagy and Type I Interferon Signaling in Host Defense

Plasma membrane rafts play a critical role in HIV-1 assembly and release

The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds

Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition

Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening. bioRxiv

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts

COVID-19) inactivation capability of copper-coated touch surface fabricated by cold-spray technology

Luminore CopperTouch™ surface coating effectively inactivates SARS-CoV-2, Ebola and Marburg viruses in vitro

Copper-oxide impregnated respiratory masks may significantly reduce the risk of SARS-CoV-2 cross contamination

A Surface Coating that Rapidly Inactivates SARS-CoV-2

Rapid Inactivation of SARS-CoV-2 by Silicon Nitride, Copper, and Aluminum Nitride

Copper and zinc absorption in the rat: mechanism of mutual antagonism

There is no conflict of interest (COI).